A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer

NCT00885755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Standard taxane therapy
DRUG: capecitabine [Xeloda]
DRUG: trastuzumab [Herceptin]

Sponsor

Hoffmann-La Roche